News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
851,249 Results
Type
Article (86744)
Company Profile (703)
Press Release (763800)
Multimedia
Podcasts (139)
Webinars (18)
Section
Business (232776)
Career Advice (4130)
Deals (39749)
Drug Delivery (129)
Drug Development (91063)
Employer Resources (198)
FDA (18160)
Job Trends (17354)
News (396714)
Policy (39798)
Tag
Academia (3002)
Academic (2)
Accelerated approval (9)
Adcomms (32)
Allergies (103)
Alliances (56945)
ALS (112)
Alzheimer's disease (1536)
Antibody-drug conjugate (ADC) (186)
Approvals (18108)
Artificial intelligence (376)
Autoimmune disease (34)
Automation (18)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (124)
Biotechnology (481)
Bladder cancer (95)
Brain cancer (37)
Breast cancer (377)
Cancer (2929)
Cardiovascular disease (235)
Career advice (3537)
Career pathing (34)
CAR-T (200)
CDC (37)
Cell therapy (551)
Cervical cancer (24)
Clinical research (74039)
Collaboration (1050)
Company closure (3)
Compensation (655)
Complete response letters (30)
COVID-19 (2894)
CRISPR (64)
C-suite (319)
Cystic fibrosis (117)
Data (2886)
Decentralized trials (2)
Denatured (48)
Depression (66)
Diabetes (337)
Diagnostics (6964)
Digital health (25)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (167)
Drug pricing (148)
Drug shortages (35)
Duchenne muscular dystrophy (125)
Earnings (97421)
Editorial (48)
Employer branding (25)
Employer resources (168)
Events (131285)
Executive appointments (891)
FDA (19776)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (962)
Gene editing (142)
Generative AI (37)
Gene therapy (419)
GLP-1 (903)
Government (5232)
Grass and pollen (6)
Guidances (180)
Healthcare (20913)
Huntington's disease (31)
IgA nephropathy (39)
Immunology and inflammation (172)
Immuno-oncology (8)
Indications (38)
Infectious disease (3071)
Inflammatory bowel disease (163)
Inflation Reduction Act (12)
Influenza (64)
Intellectual property (119)
Interviews (813)
IPO (17891)
IRA (54)
Job creations (5192)
Job search strategy (2861)
Kidney cancer (15)
Labor market (53)
Layoffs (582)
Leadership (25)
Legal (10130)
Liver cancer (84)
Lung cancer (415)
Lymphoma (200)
Machine learning (9)
Management (65)
Manufacturing (414)
MASH (92)
Medical device (14695)
Medtech (14700)
Mergers & acquisitions (22535)
Metabolic disorders (888)
Multiple sclerosis (101)
NASH (23)
Neurodegenerative disease (137)
Neuropsychiatric disorders (39)
Neuroscience (2250)
NextGen: Class of 2025 (7687)
Non-profit (5088)
Now hiring (47)
Obesity (467)
Opinion (286)
Ovarian cancer (97)
Pain (115)
Pancreatic cancer (114)
Parkinson's disease (191)
Partnered (25)
Patents (301)
Patient recruitment (144)
Peanut (54)
People (65611)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22863)
Phase II (32151)
Phase III (24203)
Pipeline (1609)
Policy (224)
Postmarket research (3552)
Preclinical (10321)
Press Release (72)
Prostate cancer (140)
Psychedelics (39)
Radiopharmaceuticals (277)
Rare diseases (496)
Real estate (7398)
Recruiting (75)
Regulatory (27018)
Reports (61)
Research institute (2663)
Resumes & cover letters (650)
Rett syndrome (9)
RNA editing (9)
RSV (54)
Schizophrenia (92)
Series A (164)
Series B (108)
Service/supplier (30)
Sickle cell disease (64)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (36)
Startups (4300)
State (2)
Stomach cancer (16)
Supply chain (80)
Tariffs (63)
The Weekly (89)
Vaccines (883)
Venture capital (52)
Weight loss (317)
Women's health (48)
Worklife (20)
Date
Today (66)
Last 7 days (536)
Last 30 days (2711)
Last 365 days (34285)
2025 (16788)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (67)
Alaska (7)
Arizona (279)
Arkansas (14)
Asia (50432)
Australia (8865)
California (7497)
Canada (2311)
China (687)
Colorado (322)
Connecticut (339)
Delaware (193)
Europe (115709)
Florida (1106)
Georgia (257)
Hawaii (1)
Idaho (65)
Illinois (714)
India (32)
Indiana (373)
Iowa (18)
Japan (218)
Kansas (115)
Kentucky (31)
Louisiana (17)
Maine (73)
Maryland (1075)
Massachusetts (5735)
Michigan (270)
Minnesota (469)
Mississippi (3)
Missouri (96)
Montana (32)
Nebraska (26)
Nevada (79)
New Hampshire (73)
New Jersey (2089)
New Mexico (31)
New York (2107)
North Carolina (1217)
North Dakota (10)
Northern California (3231)
Ohio (243)
Oklahoma (16)
Oregon (48)
Pennsylvania (1606)
Puerto Rico (18)
Rhode Island (39)
South America (1653)
South Carolina (35)
South Dakota (1)
Southern California (2762)
Tennessee (123)
Texas (1132)
United States (28348)
Utah (224)
Virginia (202)
Washington D.C. (80)
Washington State (662)
West Virginia (4)
Wisconsin (82)
There are 851,249 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
Quick on Its Feet: Novavax Adapts to Continued Regulatory Uncertainty
After the delayed approval of its next-generation COVID-19 vaccine, Novavax now awaits the first meeting of the recently overhauled CDC vaccine advisory committee next week. Throughout a tumultuous season, the Maryland-based company is relying on agility and a diverse pipeline to stay ahead of rapidly changing regulations.
June 20, 2025
·
3 min read
·
Heather McKenzie
Government
Nicole Verdun Exits FDA as CBER Director Vinay Prasad ‘Consolidates Power’
The well-respected director of the FDA’s cell and gene therapy office was seen as a stabilizing and trustworthy voice inside the quickly reshaping FDA, especially since the late-March exit of CBER Director Peter Marks.
June 20, 2025
·
3 min read
·
Dan Samorodnitsky
Press Releases
Mirion Medical to Debut New Solutions, Highlight Broad Radiopharma-Focused Portfolio at SNMMI Annual Meeting
June 19, 2025
·
3 min read
Press Releases
Fuse Oncology Announces Partnership With Elekta
June 19, 2025
·
1 min read
Press Releases
PharmaJet® and Immuno Cure Sign Agreement for Clinical Development of a Needle-free HIV Therapeutic DNA Vaccine
June 19, 2025
·
4 min read
Press Releases
MaaT Pharma Provides a Business Update and Highlights Key Milestones Expected in 2025
June 19, 2025
·
8 min read
Press Releases
Moss Genomics Announces Strategic Investment in Genomes.io
June 19, 2025
·
4 min read
Press Releases
Pulmonary Embolism Market Size to Hit USD 4.78 Billion by 2034
June 19, 2025
·
1 min read
Press Releases
MMS Wins in the 2025 Fierce CRO Awards for Excellence in Client Service and Partnership and its CEO Named CRO Champion
June 19, 2025
·
1 min read
Press Releases
Protein Therapeutics Market Set to Surge USD 740.07 Billion by 2034, Driven by Rising Demand for Biologic Treatments
June 19, 2025
·
1 min read
1 of 85,125
Next
